A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers
Clinical trial NCT03778320 · COMPLETED
Trial details
- NCT number
- NCT03778320
- Sponsor
- Concert Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2018-12-23
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.